Clinical Trial Update: FMT in Cirrhosis and Hepatic Encephalopathy [Phase 1, Phase 2]

View source ↗

Summary

This update reports the completed Phase 1 and Phase 2 trials of fecal microbiota transplantation for cirrhosis and hepatic encephalopathy, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cirrhosis
• Hepatic Encephalopathy

Drugs mentioned

• Fecal microbiota transplant (fecal microbiota transplant)

Snippet

Sponsor: VA Office of Research and Development | Conditions: Cirrhosis, Hepatic Encephalopathy | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2025-05-25